Sunphenon in Progressive Forms of Multiple Sclerosis

NCT00799890 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Sunphenon EGCG
DRUG: Placebo

Sponsor

Friedemann Paul

Collaborators

[object Object]